RayzeBio, a subsidiary of Bristol Myers Squibb, aims to develop transformative radiopharmaceutical therapies for cancer patients.
Base: $149,860 - $181,595; Bonus/Equity: Additional incentive cash and stock opportunities may be available; Benefits: Health Coverage, Wellbeing Support, Financial Well-being and Protection, Work-life benefits
Must-have
Nice-to-have
Not specified